Delivering an accredited non‐invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice

Abstract excerpt

The identification of cell-free fetal DNA circulating in maternal blood combined with technological developments, in particular next-generation sequencing, is enabling the development of safer prenatal diagnosis. While this technology has been widely applied as a highly sensitive screening test for aneuploidy, there has been relatively little clinical application for the diagnosis of monogenic disorders. In the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Fetal and Pediatric Neurological Disorders
• Share to Prenatal Screening and Diagnostics